Latest Safety News

Grange Resources reported a solid Q1 2025 with a flawless safety record, improved iron ore prices, and strategic progress on key projects despite planned maintenance impacting output and costs.

Zimplats reported a decline in mining volumes and metal output for Q3 FY2025, alongside a rise in operating costs, while advancing key capital projects on schedule.

Aeris Environmental Ltd posted solid March quarter results, driven by its AerisTech joint venture’s initial hardware and software sales and expanding consumables segment. The company is leveraging new sustainability regulations to position its smart building ecosystem for growth.

Radiopharm Theranostics has bolstered its cash position with an $8 million placement from Lantheus Holdings, now its largest shareholder. New clinical data highlight promising advances in brain metastases detection and HER2-targeted radiopharmaceutical therapies.

WA Kaolin Limited has ramped up production with new classifiers, achieving record sales and securing a $7 million capital raise, while expanding its footprint in the Chinese market.

Hillgrove Resources reported a robust March quarter with a 12% increase in copper production and a 92% rise in mine operating cash flow, underpinned by a successful $18 million capital raise to accelerate growth at Kanmantoo.

Beach Energy reported steady production and strong financials in Q3 FY25 despite flood disruptions in the Cooper Basin, with key projects advancing and liquidity improving.

GreenHy2 Limited reports a strategic push in Europe with new contracts for its advanced supercapacitor and hydrogen storage technologies, alongside a cash position of $814K and four quarters of funding runway.

Core Lithium Ltd progresses its Finniss Lithium Project Restart Study, securing full ownership of site infrastructure and reporting promising gold exploration results at Shoobridge.

Triangle Energy reported a $9.85 million cash balance for the March quarter, plugged the Becos-1 well after disappointing results, and agreed to defer the Cliff Head asset sale to Pilot Energy until 2026.

Immutep Limited has dosed the first patient in its pivotal Phase III lung cancer trial and completed enrolments in multiple studies, supported by a robust cash position expected to fund operations through 2026.

G8 Education reported a robust 2024 financial and operational performance at its 2025 AGM, highlighting strategic progress and cautious optimism for 2025 despite early occupancy headwinds.